Discovering the Full Spectrum of Cardiovascular Disease

Benjamin, Emelia J.; Jessup, Mariell; Flack, John M.; Krumholz, Harlan M.; Liu, Kiang; Nadkarni, Vinay; Rhoades, Dorothy A.; Rodríguez, Beatriz L.; Scott, Rosalyn P.; Taylor, Malcolm P.; Velázquez, Eric J.; Winkleby, Marilyn A.

doi:10.1161/01.cir.0000157742.95689.65

Cited by 33 publications

(8 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 Meanwhile, studies have documented continued racial disparities in the quality of hyperlipidemia and hypertension care. [3][4][5] Both blacks and Hispanic Americans are less likely than whites to have their cholesterol checked, to be aware of their condition, to use cholesterol-lowering medication, or to have controlled hyperlipidemia. [6][7][8][9] Studies also reveal that blacks and Hispanic Americans are more likely to have treated but uncontrolled hypertension.…”

mentioning

confidence: 99%

Race, Ethnicity, and Shared Decision Making for Hyperlipidemia and Hypertension Treatment: The DECISIONS Survey

Ratanawongsa¹,

Zikmund‐Fisher²,

Couper³

et al. 2010

Med Decis Making

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Race, Ethnicity, and Shared Decision Making for Hyperlipidemia and Hypertension Treatment: The DECISIONS Survey

Ratanawongsa¹,

Zikmund‐Fisher²,

Couper³

et al. 2010

Med Decis Making

View full text Add to dashboard Cite

show abstract

“…The mechanisms underlying these racial disparities in the level of L-arginine between hypertensive subjects of Hausa and Fulani ethnic groups are multifactorial and may include genetic factors, socioeconomic status, psychosocial stressors/risks, and other environmental factors. It has been proposed that the observed racial differences in the prevalence in cardiovascular diseases, diabetes associated with renal failure, and even pre-eclampsia occurring in pregnancy could be, at least in part, attributed to decreased NO-mediated vasodilation in various vascular beds [44]. NO-dependent vasodilation can be affected at the levels of either diminished NO production or increased NO degradation, thus rendering less NO bioavailable to target cells.…”

Section: Discussionmentioning

confidence: 99%

L-Arginine Levels among Hypertensive Patients in Sokoto, North Western Nigeria

Erhabor¹,

Ibrahim²,

Ahmed³

et al. 2017

OJBD

View full text Add to dashboard Cite

Hypertension is a major public health problem that adversely affects the health status of individuals, families and communities. L-arginine levels of a total of 90 consecutively-recruited hypertensive subjects and 50 age-matched non-hypertensive controls were studied. Plasma from subjects and control participants were analyzed for L-arginine. The mean values of L-arginine level were significantly lower among the hypertensive subjects which are (174.33 ± 78.31 µmol/L) compared to those of the 50 non-hypertensive controls (237.82 ± 261.16 µmol/L) (p = 0.04). There was no statistically significant difference in the L-arginine levels of hypertensive subjects based on gender, age and ethnicity (p = 0.87, 0.23 and 0.57) respectively. The L-arginine level was significantly higher among married hypertensive subjects (181.71 ± 78.17 µmol/L) compared to single or unmarried subjects (130.62 ± 65.99 µmol/L) (p = 0.03). The mean value of L-arginine level was significantly higher among hypertensive subjects with mild blood pressure (187.63 ± 77.93 µmol/L) compared to those with high blood pressure (156.93 ± 76.31 µmol/L). The difference however was not statistically significant (p = 0.05). The findings from this study confirm that the level of L-arginine is lower among hypertensive subjects compared to non-hypertensive controls. Age, gender and ethnicity did not have a significant effect on the L-arginine levels of hypertensive subjects. L-arginine level was significantly lower among single hypertensive patients and those with markedly raised blood pressure. It is recommended the L-arginine supplement be prescribed to hypertensive patient as a prophylactic measure. There is a need to enlighten hypertensive patients in the area on the need to maintain a balanced diet containing sufficient level of L-arginine.How to cite this paper: Erhabor, O., Ibra-

show abstract

“…Achieving CVD risk reduction and ultimately reducing death and disability from cardiovascular diseases requires specific strategies for lifestyle change and adherence to medical therapies across all racial/ethnic populations. 3, 11 …”

Section: Behavioral Interventions To Prevent Cvd or Reduce Cardiovascmentioning

confidence: 99%

“…3, 11, 116 Data are accumulating that multidisciplinary, multi-component interventions effectively reduce overall risk in underserved minority populations. A randomized clinical trial evaluating a nurse and dietitian-led case management intervention for CVD risk reduction was undertaken within a large county health care system.…”

Section: Behavioral Interventions To Prevent Cvd or Reduce Cardiovascmentioning

confidence: 99%

See 1 more Smart Citation

Behavioral Strategies for Cardiovascular Risk Reduction in Diverse and Underserved Racial/Ethnic Groups

et al. 2012

View full text Add to dashboard Cite

Discovering the Full Spectrum of Cardiovascular Disease

Cited by 33 publications

References 51 publications

Race, Ethnicity, and Shared Decision Making for Hyperlipidemia and Hypertension Treatment: The DECISIONS Survey

Race, Ethnicity, and Shared Decision Making for Hyperlipidemia and Hypertension Treatment: The DECISIONS Survey

L-Arginine Levels among Hypertensive Patients in Sokoto, North Western Nigeria

Behavioral Strategies for Cardiovascular Risk Reduction in Diverse and Underserved Racial/Ethnic Groups

Contact Info

Product

Resources

About